Key terms

About CTMX

CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest CTMX news

Apr 08 8:06am ET CytomX Therapeutics doses first patient in CX-2051 Phase 1 study by TipRanks Apr 03 8:19am ET CytomX announces $5M milestone triggered in Astellas Pharma TCB collaboration by TipRanks Mar 25 6:17am ET CytomX Therapeutics: A Balanced Hold Rating Amidst Financial Uncertainty and Clinical Progress by TipRanks Mar 22 4:23pm ET CytomX Therapeutics Welcomes New Director and Updates Bylaws by TipRanks Mar 21 8:10am ET CytomX Therapeutics appoints Zhen Su to board of directors by TipRanks Mar 18 8:08am ET CytomX Therapeutics announces milestone achievement in PROBODY TCB by TipRanks Mar 13 2:02am ET CytomX Therapeutics Braces for Increased Compliance Costs as it Outgrows ‘Smaller Company’ Status by TipRanks Mar 12 8:20am ET Analysts Conflicted on These Healthcare Names: Insmed (INSM), Oric Pharmaceuticals (ORIC) and CytomX Therapeutics (CTMX) by TipRanks Mar 12 7:29am ET CytomX Therapeutics price target lowered to $3.25 from $3.30 at BMO Capital by TipRanks Mar 12 7:10am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Legend Biotech (LEGN) and CytomX Therapeutics (CTMX) by TipRanks Mar 12 6:05am ET J.P. Morgan Keeps Their Sell Rating on CytomX Therapeutics (CTMX) by TipRanks Mar 12 4:41am ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Legend Biotech (LEGN), ACADIA Pharmaceuticals (ACAD) and CytomX Therapeutics (CTMX) by TipRanks Mar 11 8:05am ET Options Volatility and Implied Earnings Moves Today, March 11, 2024 by TipRanks Mar 01 11:04am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 29 10:57am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Feb 29 10:57am ET Biotech Alert: Searches spiking for these stocks today by TipRanks Jan 24 8:04am ET CytomX Therapeutics announces FDA clearance of IND applications for CX-2051 by TipRanks

No recent press releases are available for CTMX

CTMX Financials

1-year income & revenue

Key terms

CTMX Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

CTMX Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

People walk past the New York Stock Exchange (NYSE) on March 28, 2024 in New York City.
NDZ/STAR MAX/IPx/AP
What stalled this year’s seemingly infallible stock market rally
A working oil pumpjack is pictured in Taft, Kern County, California on September 21, 2023.
Frederic J. Brown/AFP/Getty Images
Oil prices get short-lived boost from attack on Iran
NEW YORK, NEW YORK - FEBRUARY 08: A New York Community Bank stands in Brooklyn on February 08, 2024 in New York City. New York Community Bancorp, a regional lender, shed about 60% of its value over the past eight days and its credit rating has been downgraded to Junk by Moody's. (Photo by Spencer Platt/Getty Images)
Spencer Platt/Getty Images
US regional banks are still under pressure. That’s likely to continue
Trump Media, which runs the social media platform Truth Social, took the place of Digital World's place on the Nasdaq stock exchange in March.
Frank Franklin II/AP
Trump Media stock ends session 15% higher after two very bad days